| 发明名称 |
MTA3, A MARKER FOR PREDICTING THE RESPONSE TO ANTI-CANCER DRUG IN A PATIENT WITH OVARIAN CANCER |
| 摘要 |
The present invention relates to a composition, a kit, and a method for predicting response to anticancer drug treatment in a patient with ovarian cancer, by detecting an expression level of MTA3 or a methylation level in a CpG portion of a gene of metastasis associated family, member 3 (MTA3). |
| 申请公布号 |
KR20150102595(A) |
申请公布日期 |
2015.09.07 |
| 申请号 |
KR20140024664 |
申请日期 |
2014.02.28 |
| 申请人 |
EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION |
发明人 |
PARK, YOON JUNG;PARK, AE KYUNG;AHN, JUNG HYUCK;JU, WOONG;LIM, JIN YEONG |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
